Halozyme Therapeutics, Inc. (BIT:1HALO)
Italy · Delayed Price · Currency is EUR 46.34
0.00 (0.00%)
At close: Jul 11, 2025, 5:30 PM CET
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of €6.15 billion as of July 24, 2025. Its market cap has decreased by -0.34% in one year.
Market Cap
6.15B
Enterprise Value
6.82B
Revenue
1.00B
Ranking
n/a
PE Ratio
13.70
Stock Price
€46.34
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 141.66M to 6.15B, an increase of 4,243.33%. That is a compound annual growth rate of 19.46%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 93.76B |
| Intesa Sanpaolo | 89.21B |
| Enel SpA | 78.54B |
| Ferrari | 78.25B |
| Assicurazioni Generali | 48.41B |
| Eni S.p.A. | 43.59B |
| Leonardo S.p.a. | 27.42B |
| Poste Italiane | 23.95B |